Drug Use Investigation for XYZAL®

Drug Use Investigation for XYZAL

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01445262

Enrollment

10728

Registered

2011-10-03

Start date

2011-02-28

Completion date

2013-12-31

Last updated

2015-08-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rhinitis, Allergic, Perennial and Seasonal

Brief summary

This post-marketing surveillance study (PMS) is conducted to collect safety and efficacy data among subjects with allergic rhinitis, urticaria, eczema, dermatitis, skin irritation, prurigo or pruritus cutaneous who have never been treated with levocetirizine tablets before.

Interventions

DRUGLevocetirizine

Study design

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Must be the first time for taking levocetirizine tablet

Exclusion criteria

* As this is PMS study, there are no

Design outcomes

Primary

Measure	Time frame
The number of adverse events in Japanese subjects treated with levocetirizine tablets	4 weeks

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026